Trials / Conditions / Abdominal Infection

Abdominal Infection

10 registered clinical trials studyying Abdominal Infection.

Status	Trial	Sponsor	Phase
Unknown	Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae NCT04903886	University Hospital, Brest	—
Unknown	Closed or Open Abdomen for the Management of Abdominal Sepsis NCT03163095	University of Calgary	N/A
Unknown	A Non-Traumatic Binder for Temporary Abdominal Wall Closure NCT03815370	Unity Health Toronto	N/A
Terminated	A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis NCT03090334	University of Bologna	N/A
Unknown	Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After Surgery NCT02977429	Tianjin Medical University Cancer Institute and Hospital	N/A
Completed	Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections i NCT02168946	Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)	Phase 3
Unknown	Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock NCT02191475	Tianjin Medical University Cancer Institute and Hospital	Phase 2 / Phase 3
Completed	Management and Outcome of Mesh Infection After Abdominoplasty in a Tertiary Care Centre NCT06682091	Hospices Civils de Lyon	—
Completed	Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients NCT01414959	Medical University of Vienna	—
Completed	Neutrophil CD64 and Procalcitonin as Novel Biomarkers for Postoperative Infections NCT01250574	University Hospital, Akershus	—